12/23
08:30 am
amix
Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment
Low
Report
Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment
12/19
08:44 am
amix
Autonomix Medical, Inc. Drives Towards U.S. Pivotal Trial with Appointment of Vice President, Regulatory Affairs and Quality [Yahoo! Finance]
Medium
Report
Autonomix Medical, Inc. Drives Towards U.S. Pivotal Trial with Appointment of Vice President, Regulatory Affairs and Quality [Yahoo! Finance]
12/19
08:30 am
amix
Autonomix Medical, Inc. Drives Towards U.S. Pivotal Trial with Appointment of Vice President, Regulatory Affairs and Quality
Low
Report
Autonomix Medical, Inc. Drives Towards U.S. Pivotal Trial with Appointment of Vice President, Regulatory Affairs and Quality
12/5
08:42 am
amix
Autonomix Medical, Inc. Achieves Design Lock for RF Ablation Catheter Following Successful Completion of Animal Testing, Continuing Progress Toward a U.S. Pivotal Trial in 2025 [Yahoo! Finance]
Medium
Report
Autonomix Medical, Inc. Achieves Design Lock for RF Ablation Catheter Following Successful Completion of Animal Testing, Continuing Progress Toward a U.S. Pivotal Trial in 2025 [Yahoo! Finance]
12/5
08:30 am
amix
Autonomix Medical, Inc. Achieves Design Lock for RF Ablation Catheter Following Successful Completion of Animal Testing, Continuing Progress Toward a U.S. Pivotal Trial in 2025
Medium
Report
Autonomix Medical, Inc. Achieves Design Lock for RF Ablation Catheter Following Successful Completion of Animal Testing, Continuing Progress Toward a U.S. Pivotal Trial in 2025
11/25
04:00 pm
amix
Autonomix Medical, Inc. Announces Closing of $10.0 Million Underwritten Public Offering Including Partial Exercise of Over-Allotment Option
Medium
Report
Autonomix Medical, Inc. Announces Closing of $10.0 Million Underwritten Public Offering Including Partial Exercise of Over-Allotment Option
11/22
09:19 am
amix
Autonomix Medical, Inc. Announces Pricing of $9.0 Million Underwritten Public Offering [Yahoo! Finance]
Low
Report
Autonomix Medical, Inc. Announces Pricing of $9.0 Million Underwritten Public Offering [Yahoo! Finance]
11/22
09:15 am
amix
Autonomix Medical, Inc. Announces Pricing of $9.0 Million Underwritten Public Offering
High
Report
Autonomix Medical, Inc. Announces Pricing of $9.0 Million Underwritten Public Offering
11/11
08:00 am
amix
Autonomix Medical, Inc. Reports Second Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update
Medium
Report
Autonomix Medical, Inc. Reports Second Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update
10/31
08:00 am
amix
Autonomix Medical, Inc. Reports New Positive Topline Results from First 15 Patients’ 7-Day Data Highlighting Significant Impact on Treatment of Pancreatic Cancer Pain with Maintained Pain Reduction
High
Report
Autonomix Medical, Inc. Reports New Positive Topline Results from First 15 Patients’ 7-Day Data Highlighting Significant Impact on Treatment of Pancreatic Cancer Pain with Maintained Pain Reduction
10/30
08:30 am
amix
Autonomix Medical, Inc.’s Dr. Robert Schwartz Discusses What Positive 4-6 Week Follow-Up Data Means from Lead-In Patients in Ongoing Human Clinical Trial
Medium
Report
Autonomix Medical, Inc.’s Dr. Robert Schwartz Discusses What Positive 4-6 Week Follow-Up Data Means from Lead-In Patients in Ongoing Human Clinical Trial
10/28
08:00 am
amix
Positive Preliminary Results Demonstrate Autonomix’s Proprietary RF Ablation Technology’s Ability to Reduce Opioid Use in Ongoing Human Clinical Trial
High
Report
Positive Preliminary Results Demonstrate Autonomix’s Proprietary RF Ablation Technology’s Ability to Reduce Opioid Use in Ongoing Human Clinical Trial
10/22
08:30 am
amix
Autonomix Announces Reverse Stock Split
Medium
Report
Autonomix Announces Reverse Stock Split
10/8
08:30 am
amix
Autonomix Medical, Inc. to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLC
Low
Report
Autonomix Medical, Inc. to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLC
10/3
10:09 am
amix
This Company Is Taking An Innovative, Non-Opioid Approach To Pain Management For Pancreatic Cancer [Yahoo! Finance]
Low
Report
This Company Is Taking An Innovative, Non-Opioid Approach To Pain Management For Pancreatic Cancer [Yahoo! Finance]